EV Biologics, Inc. (YECO)
- Previous Close
0.6021 - Open
0.6021 - Bid --
- Ask --
- Day's Range
0.6021 - 0.6021 - 52 Week Range
0.5630 - 1.9500 - Volume
200 - Avg. Volume
87 - Market Cap (intraday)
6.157M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-1.2400 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
32.00
EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.
www.evbiologics.comRecent News: YECO
Performance Overview: YECO
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: YECO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: YECO
Valuation Measures
Market Cap
6.16M
Enterprise Value
6.16M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
-0.25
Enterprise Value/EBITDA
0.14
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
-1.2400
Balance Sheet and Cash Flow
Total Cash (mrq)
1.81M
Total Debt/Equity (mrq)
318.53%
Levered Free Cash Flow (ttm)
--
Research Analysis: YECO
Analyst Price Targets
Fair Value
No Fair Value available for this ticker